Pharmacokinetics and safety of oseltamivir in patients with end-stage renal disease treated with automated peritoneal dialysis
about
Influenza and the patient with end-stage renal disease.Optimization of anti-infective dosing regimens during online haemodiafiltrationIdentification of new oral dosing regimens for the neuraminidase inhibitor oseltamivir in patients with moderate and severe renal impairment.Pharmacokinetics of Oral and Intravenous Oseltamivir Treatment of Severe Influenza B Virus Infection Requiring Organ Replacement Therapy.
P2860
Pharmacokinetics and safety of oseltamivir in patients with end-stage renal disease treated with automated peritoneal dialysis
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Pharmacokinetics and safety of ...... automated peritoneal dialysis
@ast
Pharmacokinetics and safety of ...... automated peritoneal dialysis
@en
type
label
Pharmacokinetics and safety of ...... automated peritoneal dialysis
@ast
Pharmacokinetics and safety of ...... automated peritoneal dialysis
@en
prefLabel
Pharmacokinetics and safety of ...... automated peritoneal dialysis
@ast
Pharmacokinetics and safety of ...... automated peritoneal dialysis
@en
P2093
P2860
P356
P1476
Pharmacokinetics and safety of ...... automated peritoneal dialysis
@en
P2093
Craig R Rayner
Kashyap Patel
Mylène Giraudon
Peter N Morcos
Richard Robson
P2860
P304
P356
10.1111/BCP.12526
P407
P577
2015-04-01T00:00:00Z